Page 9
-
Abbott lowers sales forecast on diagnostics decline, US funding cuts
Medical device sales remained a bright spot for the company, however, with more than 20% growth in diabetes devices.
-
Agilent CFO Bob McMahon resigns
Rodney Gonsalves, corporate controller and principal accounting officer, will take on interim CFO duties. Analysts said the company’s reaffirmed third-quarter guidance should reassure investors.
-
‘We are not rolling over’: J&J electrophysiology unit rebounds amid PFA rivalry
The division returned to growth in the second quarter after declining over the previous three months. Now, can the healthcare giant catch up with its rivals in pulsed field ablation?
-
News roundup
Intuitive demos telesurgery; SS Innovations marks 100 robot installs
The demonstration of a trans-Atlantic operation using Intuitive Surgical’s da Vinci 5 robot on a tissue model was a focus at the Society of Robotic Surgery meeting in France.
-
Zimmer bets on autonomous surgery with Monogram purchase
The orthopedics firm is looking to round out its robotics offerings with the planned $177 million acquisition. Some analysts questioned the value of a fully autonomous robot.
-
GT Medical closes $53M round to commercialize brain tumor device
The money will also help the company complete enrollment in a randomized controlled trial of patients with newly diagnosed brain metastases.
-
EU, Canada delay retaliatory tariffs against US
Meanwhile, Brazil announced its own countermeasures while Mexico remains confident it will reach a deal by Aug. 1.
-
Medtronic gets CE mark for robot-driven vessel-sealing device
Medtronic said its market-leading LigaSure technology can now be used with its Hugo soft tissue robotic surgery system in Europe.
-
Quest to offer Fujirebio’s FDA-cleared Alzheimer’s blood test
The company plans to make the diagnostic available to physicians and researchers this summer, expanding its portfolio beyond laboratory developed tests.
-
Zimmer agrees to distribute Getinge products to expand ASC offering
The deal allows Zimmer to sell Getinge’s infection control and surgical products alongside its orthopedic implants and robots.
-
Waters, BD biosciences unit agree to $17.5B merger
The BD business will be spun off and merged with a Waters subsidiary. Waters shares were down about 11% in early trading Monday on the news.
-
Zimmer to buy robotics firm Monogram for about $177M
Monogram Technologies’ surgical robot for total knee replacements is expected to give Zimmer Biomet’s customers more options and drive robotic knee adoption in the U.S.